THE POTENTIAL ROLE OF HDAC INHIBITORS IN DE-SILENCING LATENT HIV VIRUS
K Ververis, TC Karagiannis
Drugs of the Future | PROUS SCIENCE, SAU-THOMSON REUTERS | Published : 2013
The support of the Australian Institute of Nuclear Science and Engineering is acknowledged. TCK is a recipient of AINSE awards. TCK is a Future Fellow and Epigenomic Medicine Laboratory is supported by the Australian Research Council. Supported in part by the Victorian Government's Operational Infrastructure Support Program.